Repetition number | Healthy subjects (n = 15) | |||
---|---|---|---|---|
Phase 1, supine | Phase 1, prone | Phase 3, supine | ||
Global LWD (%) | 1 | 24.3 ± 3.6 | 22.5 ± 3.2 | 25.4 ± 4.0 |
2 | 24.7 ± 3.5 | 22.7 ± 3.3 | 25.2 ± 3.5 | |
3 | 24.8 ± 3.6 | 22.6 ± 3.1 | 25.3 ± 3.5 | |
4 | 24.9 ± 3.4 | 22.9 ± 3.2 | 25.2 ± 3.6 | |
LWD, anterior lungs (%) | 1 | 21.2 ± 3.6 | 19.7 ± 3.4 | 19.9 ± 2.9 |
2 | 21.2 ± 3.8 | 19.8 ± 3.3 | 19.9 ± 2.8 | |
3 | 21.3 ± 3.5 | 19.8 ± 3.2 | 20.0 ± 3.1 | |
4 | 21.4 ± 3.6 | 19.8 ± 3.3 | 20.0 ± 3.3 | |
LWD, mid lungs (%) | 1 | 23.5 ± 3.6 | 21.8 ± 2.7 | 22.0 ± 2.4 |
2 | 23.5 ± 3.5 | 21.9 ± 2.5 | 22.1 ± 2.3 | |
3 | 23.5 ± 3.4 | 21.9 ± 2.4 | 22.1 ± 2.5 | |
4 | 23.6 ± 3.4 | 22.0 ± 2.4 | 22.2 ± 2.7 | |
LWD, posterior lungs (%) | 1 | 28.1 ± 7.8 | 26.3 ± 4.9 | 27.2 ± 5.8 |
2 | 28.2 ± 7.2 | 26.7 ± 5.0 | 27.3 ± 5.9 | |
3 | 28.3 ± 7.6 | 26.9 ± 5.1 | 27.2 ± 5.7 | |
4 | 28.4 ± 7.5 | 27.0 ± 5.1 | 27.2 ± 5.7 |